Hide metadata

dc.date.accessioned2018-06-12T14:13:12Z
dc.date.available2018-06-12T14:13:12Z
dc.date.created2016-11-07T08:56:09Z
dc.date.issued2017
dc.identifier.citationIdland, Ane-Victoria Roser, Sala-Llonch Borza, Tom Watne, Leiv Otto Wyller, Torgeir Bruun Brækhus, Anne Zetterberg, Henrik Blennow, Kaj Walhovd, Kristine B Fjell, Anders Martin . CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults. Neurobiology of Aging. 2017, 49, 138-144
dc.identifier.urihttp://hdl.handle.net/10852/61871
dc.description.abstractCerebrospinal fluid (CSF) neurofilament light (NFL) is a marker of axonal degeneration. We tested whether CSF NFL levels predict hippocampal atrophy rate in cognitively healthy older adults independently of the established CSF Alzheimer's disease (AD) biomarkers, β-amyloid 1–42, and phosphorylated tau (P-tau). We included 144 participants in a 2-year longitudinal study with baseline CSF measures and 2 magnetic resonance images. Eighty-eight participants had full data available. A subgroup of 36 participants with very low AD risk was also studied. NFL predicted hippocampal atrophy rate independently of age, β-amyloid 1–42, and P-tau. Including NFL, P-tau, and age in the same model, higher NFL and lower P-tau predicted higher hippocampal atrophy (R2 = 0.20, NFL: β = −0.34; p = 0.003; P-tau: β = 0.27; p = 0.009). The results were upheld in the participants with very low AD risk. NFL predicted neurodegeneration in older adults with very low AD probability. We suggest that factors previously shown to be important for brain degeneration in mild cognitive impairment may also impact changes in normal aging, demonstrating that NFL is likely to indicate AD-independent, age-expected neurodegeneration.en_US
dc.languageEN
dc.publisherElsevier Science
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adultsen_US
dc.typeJournal articleen_US
dc.creator.authorIdland, Ane-Victoria
dc.creator.authorRoser, Sala-Llonch
dc.creator.authorBorza, Tom
dc.creator.authorWatne, Leiv Otto
dc.creator.authorWyller, Torgeir Bruun
dc.creator.authorBrækhus, Anne
dc.creator.authorZetterberg, Henrik
dc.creator.authorBlennow, Kaj
dc.creator.authorWalhovd, Kristine B
dc.creator.authorFjell, Anders Martin
cristin.unitcode185,17,5,0
cristin.unitnamePsykologisk institutt
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1397850
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Neurobiology of Aging&rft.volume=49&rft.spage=138&rft.date=2017
dc.identifier.jtitleNeurobiology of Aging
dc.identifier.volume49
dc.identifier.startpage138
dc.identifier.endpage144
dc.identifier.doihttp://dx.doi.org/10.1016/j.neurobiolaging.2016.09.012
dc.identifier.urnURN:NBN:no-64472
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0197-4580
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/61871/5/Post-print.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International